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and likely are part of novel cation channel family which is highly
conserved from an evolutionary point of view; it shares homology
with relevant proteins from C. elegans to humans. It is likely that
arENaC codes for the pore-forming subunit of one of the
amiloride sensitive epithelial Na channels; however, until lipid
bilayer reconstitution experiments are carried out one cannot rule
out that the arENaC codes for a regulatory protein that is
intimately related to the Na channel. Studies have, however,
demonstrated that similarly sized arENaC transcripts are present
in appropriate Na transporting tissues but are absent in tissues
such as the liver and brain. Expression of arENaC is developmen-
tally regulated in the rat and human with the timing of the
expression correlating with the lung's ability to transport Na.
Expression of arENaC is increased by glucocorticosteroid hor-
mones, which correlates with these hormone's ability to accelerate
the maturation of Na transport in the intact developing lung.
The signal transduction pathways regulating Na transport have
been extensively investigated in the kidney, and adult and perina-
tal alveolar epithelium. All three epithelia increase Na transport
when intracellular [cAMP] increases; however the responsible cell
membrane receptor is different. Although kidney epithelia can
respond to AVP, V2 membrane receptors are absent on perinatal
alveolar epithelia, thus explaining why AVP does not increase
alveolar epithelial Na transport. Similarly, the alveolar epitheli-
um's Isc is unresponsive to aldosterone stimulation, and mem-
brane permeant analogues of cGMP or PKC agonists do not
increase its Na transport. In contrast, the alveolar epithelium
increases [cAMPI and Na transport following /32 receptor stimu-
lation. The mechanism of action is complex and includes a /32
agonist induced increase in intracellular [Ca], a nearly 2 log shift
in the sensitivity of the NSC sensitivity to Ca, and a reduction in
intracellular [Cl] which directly increases the open probability of
the 25 pS amiloride-sensitive NSC in perinatal epithelium.
References
1. O'BRoDovIcH HM: Epithelial ion transport in the fetal and perinatal
lung. Am J Physiol 261:C555—C564, 1991
2. CANESSA CM, HORISBERGER JD, ROSSIER BC: Functional cloning of
the epithelial sodium channel: Relation with genes involved in neuro-
degeneration. Nature 361:467—470, 1993
3. MATALON S, BAUER M, BEN05 D, KLEYMAN T, UN C, CRAG0E EJJ,
O'BRoDovIcH HM: Fetal lung epithelial cells contain two populations
of amiloride-sensitive Na channels. Am J Physiol 264:L357—L364, 1993
4. O'Bnooovici-s HM, CANESSA C, UEDA J, RAFII B, ROSSIER BC,
EDELSON J: Expression of the epithelial Na channel in the developing
rat lung. Am J Physiol 265:C491—C496, 1993
5. T0HDA H, Fosirr JK, O'BRoDovIcu HM, MARUNAKA Y: Cl regula-
tion of a Ca activated non-selective cation channel in /3 agonist treated
fetal lung alveolar epithelium. Am J Physiol 266:C104—C109, 1994
6. CANES5A CM, SCHILD L, BUELL G, THOREN5 B, GAUTSCHI I, Hous-
BERGER J-D, R05sJER BC: Amiloride-sensitive epithelial Na channel is
made of three homologous subunits. Nature 367:463—467, 1994
exit step, usually Cl channels. Cl transport can be inhibited at both
sides of the epithelium. Loop diuretics such as furosemide,
bumetanide and torasemide inhibit binding to the Na/2C1/K-
cotransporter by their high infinity. Cl channel blockers inhibit the
Cl exit step. This mechanism of inhibition has been shown to be
very effective in the thick ascending limb of the loop of Henle
(TAL). However, the same compounds (NPPB) which inhibit Cl
absorption in the TAL at <1 mol/liter, have much less effect on
the secretion of Cl in the colon. The reason for the different
affinities of these blockers in various epithelia may be based on the
differences of the respective Cl channels. Currently much evi-
dence favors the view that the intermediate conductance out-
wardly rectifying Cl channel (ICOR) is not the key Cl exit
mechanism in epithelia such as colonic crypt cells. Rather, it
appears likely the small- or very-small-conductance Cl channels
are responsible for epithelial Cl secretion. Unlike the ICOR-
channel, these small channels are not very sensitive towards NPPB
and related compounds.
In a broad search for putative inhibitors of Cl secretion we have
also examined cromanol with the internal number 293 B. This
compound proved to be a very potent inhibitor of Cl secretion in
the colon. 293 B is a racemate. A separation of the two enanti-
omers 407 B and 434 B revealed that the latter compound is
biologically active with an 1C50 of only 250 nmol/liter from the
serosal side.
In Ussing chamber experiments we examined whether 293 B is
specific for cAMP-mediated Cl secretion. 293 B inhibited the
equivalent short circuit current produced by forskolin, 8-CPT-
cAMP, IBMX, VIP, PGE2, adenosine, and cholera toxin. It was
ineffective on the secretory Cl current produced by the Ca-
ionophore, ionomycin. To examine the effect of 293 B in more
detail, individual colonic crypts were perfused in vitro and the
voltage across the basolateral membrane (VbI) was measured. It
was shown that agonists acting via cAMP induce a rapid but
transient depolarization followed by a sustained, less pronounced
depolarization. During this phase the membrane conductance of
the impaled cell was maximal. 293 B added to the basolateral side
depolarized VbI further by 6 to 10 mV. This suggests that 293 B
reduced a K conductance. However, 293 B had no effect on the
basal K conductance, nor on the K conductance induced by ATP.
Comparable whole cell patch clamp studies in CFPAC-1 cells,
which show little or no Cl current in response to cAMP, have
revealed that 293 B also inhibited a cAMP-induced K conduc-
tance. The present data indicate that Cl transport can be inhibited
reversibly by a new class of inhibitors of the cromanol type (293
B). These substances apparently inhibit a K conductance which is
activated by cAMP. Inhibition of this conductance then limits the
amount of Cl secreted.
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Solute and fluid secretion mechanisms in ADPKD cells
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Fluid secretion is a major factor involved in renal cyst growth in
patients with autosomal dominant polycystic kidney disease. We
have begun an investigation into the nature of the solute transport
systems that drive that secretion. The data we have collected thus
far are compatible with the hypothesis that chloride secretion
drives fluid transport by the ADPKD cystic tissue. Three prepa-
rations were used in this investigation; all are derived from
kidneys removed from ADPKD patients. First, intact cysts were
dissected from these kidneys and their ability to secrete fluid was
measured. Second, monolayers of cells of primary cultures of
cystic tissue were grown on permeable supports. Their ability to
secrete fluid and their electrical properties were determined.
Third, microcysts were formed by clonal growth of cells from
primary cultures of cystic tissue. Single cysts were isolated and
video and epifluorometric techniques were used to measure fluid
secretion, cell volume and changes in cell potential and cell
chloride concentration.
Individual superficial cysts were dissected from ADPKD kid-
neys, the cyst fluid was removed and replaced with culture
medium, and a gravimetric technique was used to measure fluid
loss or gain by the cyst in 24 hour periods. A series of experiments
was performed to test the effect of the adenylate cyclase agonist,
forskolin, and ouabain on fluid transport by the isolated cysts.
Forskolin caused the cysts to secrete fluid. Ouabain, added to the
cyst cavity (apical surface) in the presence of forskolin, did not
affect secretion. Addition of the inhibitor to the bath (basolateral
surface) completely blocked fluid secretion. The results of these
experiments indicate that the location of functional Na/K-ATPase
is on the basolateral surface of these cysts.
Primary cultures were grown from the inner walls of ADPKD
cysts and confluent cultures of the resulting cells were grown on
the permeable membrane of Transwell-Col culture chambers.
Forskolin induced fluid secretion by these monolayers. The
monolayers of these cells and the supporting membrane were also
mounted in standard Ussing chambers and the transepithelial
potential difference, Tte, the short-circuit current, SCC, and tissue
resistance were measured. In 36 monolayers, the apical surface
was negative with respect to the basolateral surface and was
hyperpolarized by the addition of forskolin. SCC measurements
indicated a positive ionic current flowed from the apical to the
basolateral surface and this current was increased by forskolin.
The transepithelial resistance averaged 156 ohms cm2 and was
reduced by forskolin. These measurements are not compatible
with the thesis that the cystic tissue secretes Na. The effect of
ouabain on the forskolin-treated monolayers was also tested.
Apical application of ouabain did not affect Vte or SCC. However,
basolateral application of ouabain depolarized the monolayers
and reduced SCC nearly to zero. These data indicate that the
location of functional Na-K, ATPase is on the basolateral surface
of monolayers of cultured ADPKD tissue.
Since mislocation of Na/K-ATPase to the apical membrane and
sodium secretion could not account for fluid secretion in intact
and in cultured ADPKD tissue, we considered that secretion of
chloride may drive fluid secretion much as it does in other
secretory epithelia. We hypothesized that chloride enters the cell
across the basolateral membrane via a Na-K-2Cl cotransporter in
the basolateral membrane and exits the cell via a conductance
pathway in the apical membrane activated by cAMP. We began
our investigation of this hypothesis by applying the chloride
channel blocker, diphenylamine-2-carboxylate, DPC, to the apical
membrane of forskolin-treated monolayers. DPC depolarized the
tissue and greatly decreased the SCC. These data suggest that a
chloride channel in the apical membrane may be involved in fluid
secretion. However, much more work is needed to verify that
tentative conclusion. In the second series of experiments we
examined the effects of bumetanide, an inhibitor of the Na-K-2C1
cotransporter. Bumetanide inhibited the forskolin-induced in-
crease in SCC and depolarized Vte. These results are compatible
with the hypothesis that a Na-K-2Cl cotransporter is present in
the basolateral membrane of cystic tissue and participates in the
fluid secretion initiated by forskolin.
Microcysts grown from single, cultured ADPKD cells seeded in
a collagen matrix were isolated and placed in a superfusion
chamber on the stage of an inverted microscope. Morphometric
techniques were used to measure the rate of change in cavity
volume and the volume of the cells forming the cyst. Epifluori-
metric techniques were used to measure the changes in cell
electrical potential as reported by changes in the fluorescence of
bisoxonol, a lipophilic anion. Fluid secretion into the cystic cavity
was induced by the application of 8-bromo-cAMP. The initiation
of secretion was accompanied by a loss of cell volume and
hyperpolarization of the cell potential. Bumetanide blocked the
secretion, caused a further loss in cell volume and an additional
hyperpolarization. In preliminary experiments, changes in cell
chloride concentration were determined with the use of the
fluorescent indicator, methoxy-ethyl quinolinium (MEQ). The
application of bumetanide to a microcyst, stimulated to secrete
fluid by cAMP, caused a sharp reduction in cell chloride concen-
tration that was reversed when the inhibitor was removed. The
results obtained with the microcysts were interpreted to support
the hypothesis that chloride secretion drives fluid secretion by
cystic tissue as it does in airway epithelia and in certain cultures of
intestinal epithelia.
The data reported here did not confirm the thesis that mislo-
cation of Na/K-ATPase to the apical membrane and the secretion
of sodium is responsible for fluid secretion by ADPKD cysts. The
data did indicate that an anion is secreted by ADPKD tissue and
are compatible with the hypothesis that fluid secretion is driven by
chloride secretion.
References
1. WwsoN PD, SHERWOOD AC, P.uA K, Du J, WATSON R, NORMAN JT:
Reversed polarity of Na-K-ATPase: Mislocation to apical plasma
membranes in polycystic kidney disease epithelia. Am J Physiol 260:
F420—F430, 1991
2. YE M, GrH1, JJ: The secretion of fluid by renal cysts from
patients with autosomal dominant polycystic kidney disease. N Eng J
Med 329:310—313, [993
